Streamlining Translation of a Next-Generation Psilocybin Derivative to Reduce Behavioural Symptoms Associated with FTD
Time: 12:00 pm
day: Track 2 AM Day 2
Details:
- Expanding our understanding of non-SSRI serotonergics for symptom management of Frontotemporal Dementias (FTD)
- Presenting the effects of a non-hallucinogenic psilocybin derivative, PSIL-006, on translational biomarkers for neuroinflammation and neuroplasticity
- In vivo mouse models for neurodegeneration and psychiatric symptomology including compulsive behaviors, circadian rhythm, and apathy
